KP Tissue Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Earnings From Equity Investments	8.07	1.87	-1.86	-13.3	0.8	Upgrade
EBT Excluding Unusual Items	8.07	1.87	-1.86	-13.3	0.8	Upgrade
Gain (Loss) on Sale of Investments	0.43	0.62	1.03	0.75	0.32	Upgrade
Pretax Income	8.5	2.49	-0.83	-12.55	1.12	Upgrade
Income Tax Expense	-	0.06	4.11	-2.3	-0.12	Upgrade
Net Income	8.5	2.43	-4.94	-10.25	1.24	Upgrade
Net Income to Common	8.5	2.43	-4.94	-10.25	1.24	Upgrade
Net Income Growth	249.53%	-	-	-	-	Upgrade
Shares Outstanding (Basic)	10	10	10	10	10	Upgrade
Shares Outstanding (Diluted)	10	10	10	10	10	Upgrade
Shares Change (YoY)	0.27%	0.21%	0.20%	1.02%	1.36%	Upgrade
EPS (Basic)	0.85	0.24	-0.50	-1.03	0.13	Upgrade
EPS (Diluted)	0.85	0.24	-0.50	-1.03	0.13	Upgrade
EPS Growth	248.59%	-	-	-	-	Upgrade
Dividend Per Share	0.720	0.720	0.720	0.720	0.720	Upgrade
Effective Tax Rate	-	2.25%	-	-	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.